세계 분자 이미징 시장 : 제품 유형, 용도, 최종 사용자, 지역별

The global molecular imaging market is estimated to be valued at US$ 4.77 Bn in 2023 and is expected to exhibit a CAGR of 5.6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.77 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.60%	2030 Value Projection:	US$ 7 Bn

Figure 1. Global Molecular Imaging Market Share (%), By Product Type, 2023

Molecular imaging (MI) is a rapidly expanding biomedical research discipline that allows for the imaging, characterization, and quantification of biologic processes occurring at the cellular and subcellular levels in intact living organisms, including patients. MI pictures represent disease-related cellular and molecular pathways and mechanisms in the setting of a living patient. MI facilitates the study of biologic processes in their physiologically authentic milieu, overcoming the constraints and limits of in vitro or ex vivo biopsy and cell culture laboratory procedures. It also includes 'multiple' image-capture techniques as well as knowledge domains from cell and molecular biology, chemistry, pharmacology, medical physics, biomathematics, and bioinformatics. Modern clinical scientific researchers employ MI to investigate how molecular defects observed in cells accumulate to become the basis of disease.

Market Dynamics

The key players in the industry are focusing on the research and development for advanced techniques in the market. Thus, the introduction of such advanced products in the market is expected to drive growth of the global molecular imaging market over the forecast period. For instance, on June 20, 2023, Blue Earth Therapeutics, a Bracco company and leader in the development of innovative next-generation therapeutic radiopharmaceuticals, delivered upcoming corporate and employee presentations at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting scheduled for March 24, 2023 in Chicago, Illinois. The conference will feature presentations on clinical and preclinical research studies on therapeutic applications of radiohybrid prostate-specific membrane antigen (rhPSMA) technology. This includes early clinical experience and preclinical evaluation of 177Lu-rhPSMA-10.1, which is currently being investigated by Blue Earth Therapeutics as a potential PSMA-targeted therapeutic radiopharmaceutical candidate for the treatment of prostate cancer.

Key features of the study:

• This report provides an in-depth analysis of the global molecular imaging market and provides market size (US$ Bn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global molecular imaging market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include GE Healthcare, Bruker Corporation, Fujifilm Holdings Corp., Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, United Imaging Healthcare Co., Ltd., Mediso Kft., Positron Corporation, Esaote SpA, Carestream Health, Mirada Medical Limited and Hermes Medical Solutions
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global molecular imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular imaging market

Global Molecular Imaging Market Detailed Segmentation:

• By Product Type:
  • Devices
  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Hybrid Products (Positron Emission Tomography - Computed Tomography (PET-CT)
  • Positron Emission Tomography- Magnetic Resonance (PET-MR)
  • Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
  • Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR)
  • Software Platforms
  • On Premises Solutions
  • Cloud Based Solutions Surgical Sutures & Staplers
• By Application:
  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal
  • Other Applications
• By End User:
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Other Application
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • GE Healthcare
  • Bruker Corporation
  • Fujifilm Holdings Corp.
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • United Imaging Healthcare Co., Ltd.
  • Mediso Kft.
  • Positron Corporation
  • Esaote SpA
  • Carestream Health
  • Mirada Medical Limited
  • Hermes Medical Solutions

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Test Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Molecular Imaging Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Molecular Imaging Market, By Product Type, 2018- 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Molecular Ultrasound Imaging
• Positron Emission Tomography (PET)
• Single Photon Emission Computed Tomography (SPECT)
• Nuclear Magnetic Resonance (NMR) Spectrometer
• Hybrid Products ( Positron Emission Tomography - Computed Tomography (PET-CT)
• Positron Emission Tomography- Magnetic Resonance (PET-MR)
• Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT)
• Single Photon Emission Computed Tomography - Magnetic Resonance (SPECT-MR))
• Software Platforms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• On Premises Solutions
• Cloud Based Solutions

6. Global Molecular Imaging Market, By Application, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Gastrointestinal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

7. Global Molecular Imaging Market, By End User, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
• Diagnostic Imaging Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Others

8. Global Molecular Imaging Market, By Region, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Region/Country, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
  • GE Healthcare
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Bruker Corporation
  • Fujifilm Holdings Corp.
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • United Imaging Healthcare Co., Ltd.
  • Mediso Kft.
  • Positron Corporation
  • Esaote SpA
  • Carestream Health
  • Mirada Medical Limited
  • Hermes Medical Solutions

10. Section

• References
• Research Methodology
• About us and Sales Contact